搜尋結果
加科思(01167.HK)抑制劑新藥內地上市申請獲受理
阿思達克財經網· 7 日前加科思-B(01167.HK)公布,自主研發的KRAS G12C抑制劑產品Glecirasib(JAB-21822)新藥上市申請,已獲得 ...
Netflix Buys Sean ‘Diddy’ Combs Documentary After ‘Bidding War’
Forbes· 7 日前A docuseries about the allegations of sexual abuse, rape and sex trafficking against rapper ...
Fewer than 1 in 10 Hongkongers know how to get help for schizophrenia
South China Morning Post· 5 小時前This was despite government efforts to increase the number of social workers focusing on mental ...
Elon Musk Is Feuding With ‘AI Godfather’ Yann LeCun (Again)—Here's Why
Forbes· 12 小時前Elon Musk spent part of his Memorial Day holiday trading barbs with Meta’s AI chief Yann LeCun ...
Biden Campaign Finally Uses Trump’s Hush Money Case To Attack Him—With Robert De Niro
Forbes· 12 小時前President Joe Biden’s campaign held a press conference outside President Donald Trump’s ...
AI And The Municipal Bond Market: Oceans Of Data
Forbes· 6 日前The municipal bond market is often described as complex, opaque, and fragmented with multiple ...
How Jasmine Crockett Is Helping Women Overcome Workplace Bias
Forbes· 5 日前Crockett's experience with Greene is a stark reminder that women, especially those in ...
加科思(1167)醫肺癌新藥上市申請獲受理,納入優先審評程序 - 香港經濟日報 - 投資頻道 - 大市 - D240522
經濟日報· 7 日前《經濟通通訊社22日專訊》加科思-B(01167)公布,自主研發的KRAS G12C抑制劑Glecirasib(JAB-21822 ...
TS Galaxy coach Sead Ramovic responds to Mamelodi Sundowns' Rhulani Mokwena's ...
Goal.com· 5 日前The Rockets mentor Ramovic could not resist throwing jabs at the "disrespectful" ...
全部 | 加科思(1167)醫肺癌新藥上市申請獲受理,納入優先審評程序 | 即時新聞 - 新股 IPO - 股票 - ...
經濟通· 7 日前etnet提供全面港股IPO上市資料,包括招股價及入場費、公司簡介及招股資料、認購反應、新股孖展、暗盤報價、保薦人、基石投資者、解禁日及解禁金額、新股新 ...